EVALUATION OF THE INCREASED PERCENTAGE OF SPONGY BONE IN CASES OF EXPERIMENTAL OSTEOPOROSIS TREATED WITH SYNTHETIC ANABOLIC AGENTS

被引：0
|
作者：
CARROZZO, M
PALLANTE, R
LOSASSO, F
DAMORE, M
机构：
来源：
REVUE DU RHUMATISME | 1983年 / 50卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：501 / 505
页数：5
相关论文
共 50 条
  • [1] Anabolic bone agents evaluation in experimental bone defects.
    Aybar, A
    Territoriale, E
    Kozuszko, S
    Juarez, J
    Missana, L
    JOURNAL OF DENTAL RESEARCH, 2003, 82 : 53 - 53
  • [2] Bone anabolic agents in the treatment of patients with osteoporosis
    Rizzoli, R
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 49 - 49
  • [3] Targeting the osteoblast: approved and experimental anabolic agents for the treatment of osteoporosis
    Toulis, Konstantinos A.
    Anastasilakis, Athanasios D.
    Polyzos, Stergios A.
    Makras, Polyzois
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2011, 10 (03): : 174 - 195
  • [4] Targeting the osteoblast: approved and experimental anabolic agents for the treatment of osteoporosis
    Konstantinos A. Toulis
    Athanasios D. Anastasilakis
    Stergios A. Polyzos
    Polyzois Makras
    Hormones, 2011, 10 : 174 - 195
  • [5] Assessment of Bone Quality in Osteoporosis Treatment with Bone Anabolic Agents: Really Something New?
    Ulivieri, Fabio M.
    Caudarella, Renata
    Camisasca, Marzia
    Cabrini, Daniela M.
    Merli, Ilaria
    Messina, Carmelo
    Piodi, Luca P.
    CURRENT RHEUMATOLOGY REVIEWS, 2018, 14 (01) : 53 - 61
  • [6] Synthesis and biological evaluation of prostaglandin-F alkylphosphinic acid derivatives as bone anabolic agents for the treatment of osteoporosis
    Soper, DL
    Milbank, JBJ
    Mieling, GE
    Dirr, MJ
    Kende, AS
    Cooper, R
    Jee, WSS
    Yao, W
    Chen, JL
    Bodman, M
    Lundy, MW
    De, B
    Stella, ME
    Ebetino, FH
    Wang, YL
    deLong, MA
    Wos, JA
    JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (24) : 4157 - 4169
  • [7] Treatment of Osteoporosis With Anabolic Agents and the Risk of Primary Bone Cancers: A Study of 44,728 Patients Treated With Teriparatide and Abaloparatide
    McDonald, Christopher L.
    Johnson, Keir
    Alsoof, Daniel
    Molino, Janine
    Balmaceno-Criss, Mariah
    Daniels, Alan H.
    JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS, 2023, 31 (10) : 520 - 528
  • [8] The design and synthesis of selective prostaglandin analogs as bone anabolic agents for the potential treatment of osteoporosis
    Soper, DL
    Wang, YL
    De, BW
    DeLong, MA
    Dirr, MJ
    Soehner, ME
    Lundy, MW
    Mieling, GE
    Wos, JA
    EICOSANOIDS AND OTHER BIOACTIVE LIPIDS IN CANCER, INFLAMMATION, AND RADIATION INJURY, 5, 2002, 507 : 303 - 307
  • [9] Tryptophan Hydroxylase 1 (Tph-1)-Targeted Bone Anabolic Agents for Osteoporosis
    Fu, Hai-Jian
    Zhou, Yu-Ren
    Bao, Bei-Hua
    Jia, Meng-Xuan
    Zhao, Yang
    Zhang, Lei
    Li, Jian-Xin
    He, Hai-Lang
    Zhou, Xian-Mei
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (11) : 4692 - 4709
  • [10] Two cases of calciphylaxis treated by parathyroidectomy: importance of increased bone formation
    Maeda, H.
    Tokumoto, M.
    Yotsueda, H.
    Taniguchi, M.
    Tsuruya, K.
    Hirakata, H.
    Iida, M.
    CLINICAL NEPHROLOGY, 2007, 67 (06) : 397 - 402
12345